Do You Qualify for Ofev (nintedanib) Coverage by Aetna (CVS Health) in Washington? Decision Tree & Next Steps

Answer Box: Your Path to Ofev (nintedanib) Coverage

If you have IPF, SSc-ILD, or progressive fibrosing ILD diagnosed by a pulmonologist with HRCT evidence, you likely qualify for Ofev coverage by Aetna (CVS Health). Required: pulmonologist prescription, HRCT showing fibrosis, recent PFTs (FVC ≥50% predicted, DLCO ≥30%), and baseline liver tests. Submit via your provider's Aetna portal or fax to 1-877-309-8077. Standard approval takes 5-14 business days. If denied, Washington residents have strong appeal rights including independent external review through the Office of the Insurance Commissioner (1-800-562-6900).

Table of Contents

  1. How to Use This Decision Tree
  2. Eligibility Triage: Do You Qualify?
  3. If "Likely Eligible": Your Action Plan
  4. If "Possibly Eligible": Tests You Need
  5. If "Not Yet": Alternative Options
  6. If Denied: Washington Appeal Process
  7. Common Denial Reasons & Solutions
  8. Costs & Financial Support
  9. FAQ

How to Use This Decision Tree

This guide helps you determine if you qualify for Ofev (nintedanib) coverage through Aetna (CVS Health) in Washington state. Work through each section based on your current situation:

  • Start with the eligibility triage to see where you stand
  • Follow the specific action plan for your category
  • Use Washington's strong appeal rights if initially denied
Note: This is not medical advice. Always work with your pulmonologist to determine the best treatment approach.

Eligibility Triage: Do You Qualify?

✅ Likely Eligible

You probably qualify if you have ALL of these:

  • Confirmed diagnosis of IPF, SSc-ILD, or chronic fibrosing ILD with progressive phenotype
  • Pulmonologist care (required for prescription)
  • HRCT evidence showing UIP pattern or ≥10% lung fibrosis
  • Recent PFTs with FVC ≥50% predicted and DLCO ≥30% predicted
  • Age 18+ and nonsmoker status
  • Normal liver function (ALT/AST within 1.5x normal)

⚠️ Possibly Eligible

You might qualify but need additional documentation if:

  • Your HRCT shows "probable UIP" or indeterminate findings
  • You have borderline PFT values (FVC 45-50%, DLCO 25-30%)
  • Your diagnosis is recent and progression isn't well-documented
  • You're currently on other immunosuppressive therapy

❌ Not Yet Eligible

You likely don't qualify currently if:

  • No confirmed ILD diagnosis or HRCT findings
  • PFTs show FVC <45% or DLCO <25% predicted
  • Active smoking or recent smoking history
  • Significant liver dysfunction
  • Already on Esbriet (pirfenidone) without documented failure

If "Likely Eligible": Your Action Plan

Document Checklist

Gather these before your pulmonologist submits the prior authorization:

Document What's Needed Where to Get It
HRCT Report Full radiology report showing UIP pattern or fibrosis extent Imaging center or pulmonologist
PFT Results Within 12 months: FVC, DLCO, TLC values Pulmonary function lab
Liver Function Tests ALT, AST, bilirubin within 30 days Any lab facility
Specialist Notes Pulmonologist confirmation of diagnosis and treatment rationale Pulmonologist office
Prior Therapy Records Documentation of previous treatments if applicable Medical records

Submission Path

  1. Provider submits via Aetna provider portal or fax to 1-877-309-8077
  2. Standard review takes 5-14 business days (up to 45 days maximum)
  3. Expedited review available for urgent cases (72 hours)
  4. Auto-approval if Aetna doesn't respond within required timeframes
Tip: Ask your pulmonologist's office to request expedited review if your condition is rapidly progressing.

If "Possibly Eligible": Tests You Need

Missing Diagnostics to Request

  • Surgical lung biopsy if HRCT is indeterminate for UIP pattern
  • Repeat PFTs if borderline values (may need to wait for documented decline)
  • 6-minute walk test to document functional limitation
  • Echocardiogram to rule out pulmonary hypertension as primary cause

Timeline to Re-apply

  • Wait 3-6 months for clear progression documentation
  • Repeat PFTs showing ≥10% FVC decline supports progressive phenotype
  • Track symptoms with standardized questionnaires (dyspnea scales)

If "Not Yet": Alternative Options

Treatments to Discuss with Your Pulmonologist

  • Pirfenidone (Esbriet) - Alternative antifibrotic with similar efficacy
  • Supportive care - Oxygen therapy, pulmonary rehabilitation
  • Clinical trials - Emerging treatments like nerandomilast, inhaled treprostinil
  • Immunosuppression - For connective tissue disease-associated ILD

Preparing for Exception Requests

Even if standard criteria aren't met, you can request a formulary exception with:

  • Detailed medical necessity letter from pulmonologist
  • Evidence of contraindications to alternatives
  • Documentation of unique clinical circumstances

If Denied: Washington Appeal Process

Washington residents have exceptionally strong appeal rights through multiple levels:

Internal Appeals (Required First Step)

Timeline: File within 180 days of denial Process: Submit to Aetna member services with:

  • Original denial letter
  • Complete medical records
  • Physician statement of medical necessity
  • Any new supporting evidence

Decision: 30 days standard, 72 hours expedited

External Review (Independent & Binding)

If internal appeals fail, Washington's Office of the Insurance Commissioner provides free external review:

Contact: 1-800-562-6900 or insurance.wa.gov Timeline: File within 4 months of final internal denial Cost: Free to you (insurer pays) Decision: Binding on Aetna if overturned Success Rate: External reviews overturn approximately 40% of denials nationwide

Washington Advantage: The state's new Specialist Care Access Act (effective March 2025) requires specialist-to-specialist review, meaning pulmonology denials must be reviewed by pulmonologists.

When Aetna Misses Deadlines

If Aetna doesn't respond within required timeframes for internal appeals, you can escalate directly to external review through the Washington Office of the Insurance Commissioner.

Common Denial Reasons & Solutions

Denial Reason Solution Documents Needed
Missing HRCT Submit complete radiology report Full HRCT with radiologist interpretation
Insufficient PFTs Provide recent tests meeting thresholds PFTs within 12 months showing required values
No specialist prescription Get pulmonologist to prescribe Specialist notes and prescription
Step therapy required Document failure/contraindication to alternatives Prior therapy records, side effect documentation
Non-formulary status Request formulary exception Medical necessity letter, alternative failures
"Experimental" claim Provide FDA approval evidence FDA labeling, peer-reviewed studies

Costs & Financial Support

Manufacturer Programs

Boehringer Ingelheim CareConnect4Me:

  • Copay assistance for eligible patients
  • Prior authorization support
  • Appeals assistance

BI Cares Patient Assistance:

  • Free medication for qualifying low-income patients
  • Income-based eligibility requirements

Typical Costs

  • Cash price: $13,000-$15,000 per month
  • With insurance: Varies by plan (specialty tier copays typically $50-$500/month)
  • Medicare: Subject to 2025 drug price negotiations

Frequently Asked Questions

Q: How long does Aetna prior authorization take in Washington? A: Standard review is 5-14 business days, with a maximum of 45 days. Expedited reviews are completed within 72 hours for urgent cases.

Q: What if Ofev is non-formulary on my plan? A: You can request a formulary exception with medical necessity documentation. Aetna must respond within 72 hours for standard requests, 24 hours for urgent cases.

Q: Can I request an expedited appeal? A: Yes, if your health could be in serious jeopardy without treatment. Washington requires expedited external review decisions within 72 hours.

Q: Does step therapy apply if I've tried treatments outside Washington? A: Yes, prior therapy documentation from any state is typically accepted. Provide complete records of treatments tried and outcomes.

Q: What happens if I can't afford Ofev even with insurance? A: Contact Boehringer Ingelheim's patient assistance programs. The manufacturer offers both copay cards and free medication programs based on income.

Q: How successful are appeals for specialty medications in Washington? A: External reviews overturn about 40% of insurance denials nationwide. Washington's specialist-to-specialist review requirement may improve success rates for pulmonology medications.


From our advocates: "We've seen patients initially denied for 'insufficient progression documentation' successfully appeal by submitting a comprehensive timeline showing FVC decline over 6-12 months, even when the decline was modest. The key was having the pulmonologist clearly explain why the rate of decline warranted immediate intervention to prevent further irreversible lung damage."


For patients navigating complex prior authorization requirements like those for Ofev, Counterforce Health specializes in turning insurance denials into targeted, evidence-backed appeals. The platform analyzes denial letters and plan policies to draft point-by-point rebuttals aligned with each payer's specific requirements, pulling the right medical evidence and weaving it into appeals that meet procedural requirements while tracking deadlines and required documentation.

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Always consult with your healthcare provider about treatment decisions and work with qualified professionals for insurance appeals. Coverage policies and procedures may change; verify current requirements with your insurer and the Washington Office of the Insurance Commissioner.

Sources & Further Reading

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.